nodes	percent_of_prediction	percent_of_DWPC	metapath
Prazosin—ADRA2A—attention deficit hyperactivity disorder	0.695	1	CbGaD
Prazosin—ORM1—saliva—attention deficit hyperactivity disorder	0.00731	0.0803	CbGeAlD
Prazosin—MT3—forebrain—attention deficit hyperactivity disorder	0.00536	0.0589	CbGeAlD
Prazosin—KCNH6—forebrain—attention deficit hyperactivity disorder	0.00382	0.042	CbGeAlD
Prazosin—Doxazosin—ADRA2A—attention deficit hyperactivity disorder	0.00327	1	CrCbGaD
Prazosin—MT3—nervous system—attention deficit hyperactivity disorder	0.00291	0.032	CbGeAlD
Prazosin—KCNH7—nervous system—attention deficit hyperactivity disorder	0.00291	0.032	CbGeAlD
Prazosin—MT3—central nervous system—attention deficit hyperactivity disorder	0.0028	0.0308	CbGeAlD
Prazosin—KCNH7—central nervous system—attention deficit hyperactivity disorder	0.0028	0.0308	CbGeAlD
Prazosin—MT3—cerebellum—attention deficit hyperactivity disorder	0.00274	0.0301	CbGeAlD
Prazosin—KCNH7—cerebellum—attention deficit hyperactivity disorder	0.00274	0.0301	CbGeAlD
Prazosin—KCNH7—brain—attention deficit hyperactivity disorder	0.00222	0.0244	CbGeAlD
Prazosin—MT3—brain—attention deficit hyperactivity disorder	0.00222	0.0244	CbGeAlD
Prazosin—ADRA1D—forebrain—attention deficit hyperactivity disorder	0.00212	0.0233	CbGeAlD
Prazosin—KCNH6—nervous system—attention deficit hyperactivity disorder	0.00207	0.0228	CbGeAlD
Prazosin—KCNH6—central nervous system—attention deficit hyperactivity disorder	0.002	0.0219	CbGeAlD
Prazosin—SLC22A1—forebrain—attention deficit hyperactivity disorder	0.0016	0.0175	CbGeAlD
Prazosin—KCNH6—brain—attention deficit hyperactivity disorder	0.00158	0.0174	CbGeAlD
Prazosin—HTR1D—forebrain—attention deficit hyperactivity disorder	0.00158	0.0174	CbGeAlD
Prazosin—HTR1D—cardiovascular system—attention deficit hyperactivity disorder	0.00134	0.0147	CbGeAlD
Prazosin—HTR1A—forebrain—attention deficit hyperactivity disorder	0.00132	0.0145	CbGeAlD
Prazosin—ADRA1A—forebrain—attention deficit hyperactivity disorder	0.00122	0.0134	CbGeAlD
Prazosin—ADRA1B—nervous system—attention deficit hyperactivity disorder	0.00117	0.0129	CbGeAlD
Prazosin—KCNH2—forebrain—attention deficit hyperactivity disorder	0.00117	0.0129	CbGeAlD
Prazosin—ADRA1D—nervous system—attention deficit hyperactivity disorder	0.00115	0.0126	CbGeAlD
Prazosin—ADRA1B—central nervous system—attention deficit hyperactivity disorder	0.00113	0.0124	CbGeAlD
Prazosin—HTR1A—cardiovascular system—attention deficit hyperactivity disorder	0.00111	0.0123	CbGeAlD
Prazosin—ADRA1D—central nervous system—attention deficit hyperactivity disorder	0.00111	0.0122	CbGeAlD
Prazosin—HTR1D—midbrain—attention deficit hyperactivity disorder	0.00104	0.0115	CbGeAlD
Prazosin—ADRA1A—cardiovascular system—attention deficit hyperactivity disorder	0.00103	0.0113	CbGeAlD
Prazosin—KCNH2—cardiovascular system—attention deficit hyperactivity disorder	0.000992	0.0109	CbGeAlD
Prazosin—ORM1—nervous system—attention deficit hyperactivity disorder	0.000946	0.0104	CbGeAlD
Prazosin—ADRA2A—forebrain—attention deficit hyperactivity disorder	0.000924	0.0102	CbGeAlD
Prazosin—ORM1—central nervous system—attention deficit hyperactivity disorder	0.000911	0.01	CbGeAlD
Prazosin—ADRA1B—brain—attention deficit hyperactivity disorder	0.000897	0.00986	CbGeAlD
Prazosin—ADRA1D—brain—attention deficit hyperactivity disorder	0.000878	0.00965	CbGeAlD
Prazosin—HTR1A—midbrain—attention deficit hyperactivity disorder	0.00087	0.00957	CbGeAlD
Prazosin—SLC22A1—nervous system—attention deficit hyperactivity disorder	0.000866	0.00952	CbGeAlD
Prazosin—HTR1D—nervous system—attention deficit hyperactivity disorder	0.000859	0.00944	CbGeAlD
Prazosin—SLC22A1—central nervous system—attention deficit hyperactivity disorder	0.000834	0.00917	CbGeAlD
Prazosin—SLC22A3—nervous system—attention deficit hyperactivity disorder	0.000828	0.0091	CbGeAlD
Prazosin—HTR1D—central nervous system—attention deficit hyperactivity disorder	0.000827	0.00908	CbGeAlD
Prazosin—SLC22A3—central nervous system—attention deficit hyperactivity disorder	0.000797	0.00876	CbGeAlD
Prazosin—KCNH2—midbrain—attention deficit hyperactivity disorder	0.000775	0.00852	CbGeAlD
Prazosin—HTR1A—nervous system—attention deficit hyperactivity disorder	0.000716	0.00786	CbGeAlD
Prazosin—ABCG2—midbrain—attention deficit hyperactivity disorder	0.000689	0.00758	CbGeAlD
Prazosin—HTR1A—central nervous system—attention deficit hyperactivity disorder	0.000689	0.00757	CbGeAlD
Prazosin—HTR1A—cerebellum—attention deficit hyperactivity disorder	0.000673	0.0074	CbGeAlD
Prazosin—SLC22A1—brain—attention deficit hyperactivity disorder	0.000662	0.00728	CbGeAlD
Prazosin—ADRA1A—nervous system—attention deficit hyperactivity disorder	0.00066	0.00725	CbGeAlD
Prazosin—HTR1D—brain—attention deficit hyperactivity disorder	0.000656	0.00721	CbGeAlD
Prazosin—KCNH2—nervous system—attention deficit hyperactivity disorder	0.000637	0.007	CbGeAlD
Prazosin—ADRA1A—central nervous system—attention deficit hyperactivity disorder	0.000635	0.00698	CbGeAlD
Prazosin—SLC22A3—brain—attention deficit hyperactivity disorder	0.000633	0.00696	CbGeAlD
Prazosin—ADRA1A—cerebellum—attention deficit hyperactivity disorder	0.000621	0.00682	CbGeAlD
Prazosin—KCNH2—central nervous system—attention deficit hyperactivity disorder	0.000613	0.00674	CbGeAlD
Prazosin—ADRA2A—midbrain—attention deficit hyperactivity disorder	0.00061	0.00671	CbGeAlD
Prazosin—KCNH2—cerebellum—attention deficit hyperactivity disorder	0.0006	0.00659	CbGeAlD
Prazosin—HTR1A—brain—attention deficit hyperactivity disorder	0.000547	0.00601	CbGeAlD
Prazosin—CYP1A1—nervous system—attention deficit hyperactivity disorder	0.000538	0.00591	CbGeAlD
Prazosin—ABCG2—cerebellum—attention deficit hyperactivity disorder	0.000533	0.00586	CbGeAlD
Prazosin—CYP1A1—central nervous system—attention deficit hyperactivity disorder	0.000518	0.00569	CbGeAlD
Prazosin—ABCB1—forebrain—attention deficit hyperactivity disorder	0.000515	0.00566	CbGeAlD
Prazosin—ADRA1A—brain—attention deficit hyperactivity disorder	0.000504	0.00554	CbGeAlD
Prazosin—ADRA2A—nervous system—attention deficit hyperactivity disorder	0.000502	0.00551	CbGeAlD
Prazosin—KCNH2—brain—attention deficit hyperactivity disorder	0.000487	0.00535	CbGeAlD
Prazosin—ADRA2A—central nervous system—attention deficit hyperactivity disorder	0.000483	0.00531	CbGeAlD
Prazosin—ADRA2A—cerebellum—attention deficit hyperactivity disorder	0.000472	0.00519	CbGeAlD
Prazosin—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.000435	0.00478	CbGeAlD
Prazosin—ABCG2—brain—attention deficit hyperactivity disorder	0.000433	0.00476	CbGeAlD
Prazosin—CYP1A1—brain—attention deficit hyperactivity disorder	0.000411	0.00452	CbGeAlD
Prazosin—ADRA2A—brain—attention deficit hyperactivity disorder	0.000383	0.00421	CbGeAlD
Prazosin—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00034	0.00374	CbGeAlD
Prazosin—ABCB1—nervous system—attention deficit hyperactivity disorder	0.000279	0.00307	CbGeAlD
Prazosin—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.000269	0.00296	CbGeAlD
Prazosin—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.000263	0.00289	CbGeAlD
Prazosin—ABCB1—brain—attention deficit hyperactivity disorder	0.000214	0.00235	CbGeAlD
Prazosin—HTR1D—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	4.6e-05	0.000218	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	4.58e-05	0.000217	CbGpPWpGaD
Prazosin—SLC22A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	4.55e-05	0.000216	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.55e-05	0.000216	CbGpPWpGaD
Prazosin—ADRA2B—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.52e-05	0.000214	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.5e-05	0.000214	CbGpPWpGaD
Prazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	4.5e-05	0.000214	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.49e-05	0.000213	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.48e-05	0.000213	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.48e-05	0.000212	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	4.46e-05	0.000212	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.39e-05	0.000208	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.39e-05	0.000208	CbGpPWpGaD
Prazosin—HTR1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.36e-05	0.000207	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.33e-05	0.000206	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	4.33e-05	0.000206	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.33e-05	0.000205	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.32e-05	0.000205	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.31e-05	0.000204	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	4.28e-05	0.000203	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.28e-05	0.000203	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	4.19e-05	0.000199	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.18e-05	0.000198	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	4.16e-05	0.000198	CbGpPWpGaD
Prazosin—ADRA1B—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.15e-05	0.000197	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.11e-05	0.000195	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.09e-05	0.000194	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.06e-05	0.000193	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	4.05e-05	0.000192	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.05e-05	0.000192	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	4.04e-05	0.000192	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	4.03e-05	0.000191	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	4.02e-05	0.000191	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.98e-05	0.000189	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.96e-05	0.000188	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.96e-05	0.000188	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.94e-05	0.000187	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.92e-05	0.000186	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.91e-05	0.000186	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.91e-05	0.000185	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.89e-05	0.000185	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.89e-05	0.000185	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.89e-05	0.000184	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	3.89e-05	0.000184	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.84e-05	0.000183	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.83e-05	0.000182	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.83e-05	0.000182	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.82e-05	0.000182	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.8e-05	0.00018	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.78e-05	0.000179	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.78e-05	0.000179	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.75e-05	0.000178	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.74e-05	0.000177	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.72e-05	0.000177	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.71e-05	0.000176	CbGpPWpGaD
Prazosin—ADRA1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.69e-05	0.000175	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.67e-05	0.000174	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.67e-05	0.000174	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.66e-05	0.000174	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.66e-05	0.000173	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.65e-05	0.000173	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.64e-05	0.000173	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.64e-05	0.000173	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.64e-05	0.000173	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.6e-05	0.000171	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.6e-05	0.000171	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.57e-05	0.00017	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.57e-05	0.00017	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.56e-05	0.000169	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.55e-05	0.000169	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.53e-05	0.000168	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.53e-05	0.000167	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.52e-05	0.000167	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.47e-05	0.000165	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.47e-05	0.000165	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.43e-05	0.000163	CbGpPWpGaD
Prazosin—ADRA2A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.43e-05	0.000163	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.4e-05	0.000161	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.4e-05	0.000161	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.36e-05	0.00016	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.35e-05	0.000159	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.32e-05	0.000158	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.31e-05	0.000157	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.31e-05	0.000157	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	3.3e-05	0.000157	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.3e-05	0.000157	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.29e-05	0.000156	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.27e-05	0.000155	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—TPH2—attention deficit hyperactivity disorder	3.24e-05	0.000154	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.24e-05	0.000154	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.24e-05	0.000154	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.23e-05	0.000154	CbGpPWpGaD
Prazosin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	3.21e-05	0.000153	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—TPH2—attention deficit hyperactivity disorder	3.21e-05	0.000152	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.21e-05	0.000152	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.2e-05	0.000152	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.19e-05	0.000152	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—DPYD—attention deficit hyperactivity disorder	3.19e-05	0.000151	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.18e-05	0.000151	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.17e-05	0.000151	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.16e-05	0.00015	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—DPYD—attention deficit hyperactivity disorder	3.16e-05	0.00015	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	3.11e-05	0.000148	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—COMT—attention deficit hyperactivity disorder	3.1e-05	0.000147	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.09e-05	0.000146	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.08e-05	0.000146	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—MAOA—attention deficit hyperactivity disorder	3.08e-05	0.000146	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.07e-05	0.000146	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.06e-05	0.000145	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.04e-05	0.000144	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.04e-05	0.000144	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.01e-05	0.000143	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	3e-05	0.000142	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—TPH2—attention deficit hyperactivity disorder	2.99e-05	0.000142	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.99e-05	0.000142	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.99e-05	0.000142	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.98e-05	0.000141	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.97e-05	0.000141	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.96e-05	0.000141	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.95e-05	0.00014	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—DPYD—attention deficit hyperactivity disorder	2.94e-05	0.00014	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.94e-05	0.000139	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.93e-05	0.000139	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.9e-05	0.000138	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.89e-05	0.000137	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.87e-05	0.000136	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.83e-05	0.000134	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.8e-05	0.000133	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.78e-05	0.000132	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.77e-05	0.000131	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.75e-05	0.000131	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.75e-05	0.00013	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.73e-05	0.00013	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.72e-05	0.000129	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.7e-05	0.000128	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.7e-05	0.000128	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	2.67e-05	0.000127	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.66e-05	0.000126	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.65e-05	0.000126	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.59e-05	0.000123	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.57e-05	0.000122	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.56e-05	0.000122	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.55e-05	0.000121	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.54e-05	0.00012	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—TPH2—attention deficit hyperactivity disorder	2.53e-05	0.00012	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.53e-05	0.00012	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.53e-05	0.00012	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.53e-05	0.00012	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.51e-05	0.000119	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—DPYD—attention deficit hyperactivity disorder	2.49e-05	0.000118	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.47e-05	0.000117	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.47e-05	0.000117	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.46e-05	0.000117	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	2.45e-05	0.000116	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.44e-05	0.000116	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.4e-05	0.000114	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.39e-05	0.000114	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.39e-05	0.000113	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.35e-05	0.000112	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.35e-05	0.000111	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.32e-05	0.00011	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.32e-05	0.00011	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.32e-05	0.00011	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.32e-05	0.00011	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.27e-05	0.000108	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.24e-05	0.000106	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.24e-05	0.000106	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.23e-05	0.000106	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.21e-05	0.000105	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—TPH2—attention deficit hyperactivity disorder	2.19e-05	0.000104	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.19e-05	0.000104	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.17e-05	0.000103	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.16e-05	0.000103	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—DPYD—attention deficit hyperactivity disorder	2.16e-05	0.000102	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.15e-05	0.000102	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—EP300—attention deficit hyperactivity disorder	2.14e-05	0.000102	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.13e-05	0.000101	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.13e-05	0.000101	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.1e-05	9.96e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.09e-05	9.91e-05	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.08e-05	9.89e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.08e-05	9.89e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.05e-05	9.74e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.05e-05	9.74e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.03e-05	9.62e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.03e-05	9.61e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.01e-05	9.52e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.99e-05	9.43e-05	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—COMT—attention deficit hyperactivity disorder	1.96e-05	9.32e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.96e-05	9.31e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.96e-05	9.28e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.95e-05	9.27e-05	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—MAOA—attention deficit hyperactivity disorder	1.95e-05	9.25e-05	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—COMT—attention deficit hyperactivity disorder	1.94e-05	9.22e-05	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.94e-05	9.19e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.93e-05	9.16e-05	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—MAOA—attention deficit hyperactivity disorder	1.93e-05	9.16e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.89e-05	8.99e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.89e-05	8.96e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.82e-05	8.65e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.82e-05	8.65e-05	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—COMT—attention deficit hyperactivity disorder	1.81e-05	8.6e-05	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—MAOA—attention deficit hyperactivity disorder	1.8e-05	8.54e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.8e-05	8.53e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.77e-05	8.41e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.77e-05	8.38e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.76e-05	8.35e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.75e-05	8.32e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	1.75e-05	8.32e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.75e-05	8.32e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.74e-05	8.24e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	1.72e-05	8.18e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.71e-05	8.14e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.69e-05	8.04e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.67e-05	7.92e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.64e-05	7.79e-05	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—EP300—attention deficit hyperactivity disorder	1.62e-05	7.71e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.6e-05	7.61e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.6e-05	7.58e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.59e-05	7.56e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—COMT—attention deficit hyperactivity disorder	1.54e-05	7.29e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—MAOA—attention deficit hyperactivity disorder	1.52e-05	7.23e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.52e-05	7.2e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.48e-05	7.04e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.4e-05	6.65e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.37e-05	6.5e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.33e-05	6.33e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—COMT—attention deficit hyperactivity disorder	1.33e-05	6.31e-05	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—EP300—attention deficit hyperactivity disorder	1.33e-05	6.31e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.32e-05	6.27e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—MAOA—attention deficit hyperactivity disorder	1.32e-05	6.26e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.28e-05	6.07e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.26e-05	5.98e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.12e-05	5.31e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	1.06e-05	5.04e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	1.05e-05	5e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.04e-05	4.93e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—EP300—attention deficit hyperactivity disorder	9.39e-06	4.46e-05	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—EP300—attention deficit hyperactivity disorder	8.42e-06	4e-05	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—EP300—attention deficit hyperactivity disorder	8.33e-06	3.96e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.04e-06	3.81e-05	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—EP300—attention deficit hyperactivity disorder	7.77e-06	3.69e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.25e-06	3.44e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7e-06	3.32e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.67e-06	3.17e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—EP300—attention deficit hyperactivity disorder	6.58e-06	3.12e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.92e-06	2.81e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—EP300—attention deficit hyperactivity disorder	5.7e-06	2.71e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.5e-06	2.61e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	4.55e-06	2.16e-05	CbGpPWpGaD
